Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-12

Clinical Trial Update: Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction

View source ↗

Summary

This clinical trial compares tirzepatide to semaglutide in people with type 2 diabetes mellitus and heart failure with preserved ejection fraction; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (tirzepatide)
  • semaglutide (semaglutide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type 2 Diabetes, Heart Failure | Status: ACTIVE_NOT_RECRUITING